Tumor Ablator Trials Travel Drug Path, But Sponsor Seeks Device Regulation
Genetronics Biomedical is in talks with FDA to pursue clinical development of the MedPulsor tumor ablation system through a device regulatory route
Genetronics Biomedical is in talks with FDA to pursue clinical development of the MedPulsor tumor ablation system through a device regulatory route